GSAC — GELSTAT CORP

OTC · Health Care · Pharmaceuticals · CIK 890725 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.
No quarterly fundamentals indexed for this ticker.

Yahoo Snapshot (yfinance, live)

Total Revenue
$363,533
EBITDA
$-168,888
Free Cash Flow
$-34,358
Enterprise Value
$1,895,343
Total Cash
$76,407
Total Debt
$849,620
Shares Out
3,740,434,945
Trailing EPS
$0.00
Book Value
$0.00
ROE
ROA
-50.5%
Div Yield

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $949.47B $1064.74
JNJ JOHNSON & JOHNSON $554.09B $230.18
ABBV AbbVie Inc. $376.54B $213.12
MRK Merck & Co., Inc. $295.69B $119.72
AZN ASTRAZENECA PLC $290.30B $187.19

News headlines (Yahoo Finance, 1h cache)

GSAC Engineering Secures Multi-Year Recurring Revenue Contract
2025-06-10 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.